Vivan J M Baggen1, Annemien E van den Bosch2, Roland R van Kimmenade3, Jannet A Eindhoven2, Maarten Witsenburg2, Judith A A E Cuypers2, Frank W G Leebeek4, Eric Boersma5, Jolien W Roos-Hesselink6. 1. Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands; Cardiovascular Research School COEUR, Rotterdam, The Netherlands. 2. Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands. 3. Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands; Department of Cardiology, Maastricht University Medical Center, Maastricht, The Netherlands. 4. Department of Hematology, Erasmus Medical Center, Rotterdam, The Netherlands. 5. Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands; Cardiovascular Research School COEUR, Rotterdam, The Netherlands; Department of Clinical Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands. 6. Department of Cardiology, Erasmus Medical Center, Rotterdam, The Netherlands. Electronic address: j.roos@erasmusmc.nl.
Abstract
BACKGROUND: Red cell distribution width (RDW) is a standard component of the automated blood count, and is of prognostic value in heart failure and coronary heart disease. We investigated the association between RDW and cardiovascular events in patients with adult congenital heart disease (ACHD). METHODS AND RESULTS: In this prospective cohort study, 602 consecutive patients with ACHD who routinely visited the outpatient clinic were enrolled between 2011 and 2013. RDW was measured in fresh venous blood samples at inclusion in 592 patients (median age 33 [IQR 25-41] years, 58% male, 90% NYHA I) and at four annual follow-up visits. During 4.3 [IQR 3.8-4.7] years of follow-up, the primary endpoint (death, heart failure, hospitalization, arrhythmia, thromboembolic events, cardiac intervention) occurred in 196 patients (33%). Median RDW was 13.4 (12.8-14.1)% versus 12.9 (12.5-13.4)% in patients with and without the primary endpoint (P < 0.001). RDW was significantly associated with the endpoint when adjusted for age, sex, clinical risk factors, CRP, and NT-proBNP (HR 1.20; 95% CI 1.06-1.35; P = 0.003). The C-index of the model including RDW was slightly, but significantly (P = 0.005) higher than the model without (0.74, 95% CI 0.70-0.78 versus 0.73, 95% CI 0.69-0.78). Analysis of repeated RDW measurements (n = 2449) did not show an increase in RDW prior to the occurrence of the endpoint. CONCLUSIONS: RDW is associated with cardiovascular events in patients with ACHD, independently of age, sex, clinical risk factors, CRP, and NT-proBNP. This readily available biomarker could therefore be considered as an additive biomarker for risk stratification in these patients.
BACKGROUND: Red cell distribution width (RDW) is a standard component of the automated blood count, and is of prognostic value in heart failure and coronary heart disease. We investigated the association between RDW and cardiovascular events in patients with adult congenital heart disease (ACHD). METHODS AND RESULTS: In this prospective cohort study, 602 consecutive patients with ACHD who routinely visited the outpatient clinic were enrolled between 2011 and 2013. RDW was measured in fresh venous blood samples at inclusion in 592 patients (median age 33 [IQR 25-41] years, 58% male, 90% NYHA I) and at four annual follow-up visits. During 4.3 [IQR 3.8-4.7] years of follow-up, the primary endpoint (death, heart failure, hospitalization, arrhythmia, thromboembolic events, cardiac intervention) occurred in 196 patients (33%). Median RDW was 13.4 (12.8-14.1)% versus 12.9 (12.5-13.4)% in patients with and without the primary endpoint (P < 0.001). RDW was significantly associated with the endpoint when adjusted for age, sex, clinical risk factors, CRP, and NT-proBNP (HR 1.20; 95% CI 1.06-1.35; P = 0.003). The C-index of the model including RDW was slightly, but significantly (P = 0.005) higher than the model without (0.74, 95% CI 0.70-0.78 versus 0.73, 95% CI 0.69-0.78). Analysis of repeated RDW measurements (n = 2449) did not show an increase in RDW prior to the occurrence of the endpoint. CONCLUSIONS: RDW is associated with cardiovascular events in patients with ACHD, independently of age, sex, clinical risk factors, CRP, and NT-proBNP. This readily available biomarker could therefore be considered as an additive biomarker for risk stratification in these patients.
Authors: Laura M Wienecke; Sarah Cohen; Johann Bauersachs; Alexandre Mebazaa; Benjamin G Chousterman Journal: Heart Fail Rev Date: 2021-12-02 Impact factor: 4.654